Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

Journal: Nature Genetics

Published: 2020-02-05

DOI: 10.1038/s41588-019-0562-0

Affiliations: 115

Authors: 123

Go to article
Institutions Share
USC Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Spain 0.06
Sanger Institute Cancer, Ageing and Somatic Mutation Programme, United Kingdom (UK) 0.06
Broad Institute of MIT and Harvard, United States of America (USA) 0.05
Barcelona Supercomputing Center (BSC), Spain 0.05
Wellcome Trust Genome Campus, United Kingdom (UK) 0.03
USC Department of Zoology, Genetics and Physical Anthropology, Spain 0.03
Biomedical Research Centre (CINBIO), UVIGO, Spain 0.03
EMBL Genome Biology Research Unit, Germany 0.03
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.02
McKusick-Nathans Institute of Genetic Medicine, JHU, United States of America (USA) 0.02
Harvard Department of Biomedical Informatics (DBMI), United States of America (USA) 0.02
Yale Department of Molecular Biophysics and Biochemistry (MBB), United States of America (USA) 0.02
Sir Peter MacCallum Department of Oncology, UniMelb, Australia 0.02
Peter MacCallum Cancer Centre (Peter Mac), Australia 0.02
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Human Genetics, McGill University, Canada 0.02
MRC Cancer Unit, University of Cambridge, United Kingdom (UK) 0.02
Transmissible Cancer Group (TCG), University of Cambridge, United Kingdom (UK) 0.02
Division of Applied Bioinformatics, DKFZ, Germany 0.01
Division of Genetics and Genomics, BCH, United States of America (USA) 0.01
Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, United States of America (USA) 0.01
Department of Cancer Biology, DFCI, United States of America (USA) 0.01
Department of Internal Medicine, SNU, South Korea 0.01
Catalan Institution for Research and Advanced Studies (ICREA), Spain 0.01
Department of Biochemistry, Genetics and Immunology, UVIGO, Spain 0.01
Ludwig Center at Harvard Medical School, United States of America (USA) 0.01
Department of Medical Oncology, DFCI, United States of America (USA) 0.01
Institute for Molecular Bioscience (IMB), UQ, Australia 0.01
The Francis Crick Institute, United Kingdom (UK) 0.01
University of Cambridge, United Kingdom (UK) 0.01
Harvard Medical School (HMS), United States of America (USA) 0.01
Biotech Research and Innovation Centre (BRIC), UCPH, Denmark 0.01
Finsen Laboratory, Rigshospitalet, Denmark 0.01
Yale Interdepartmental Program in Computational Biology and Bioinformatics, United States of America (USA) 0.01
Center for Reproductive Biology, United States of America (USA) 0.01
Department of Human Genetics, KU Leuven, Belgium 0.01
Sidra Medical and Research Center, Qatar 0.01
Azrieli Faculty of Medicine, BIU, Israel 0.01
Johns Hopkins University School of Medicine (JHUSOM), JHU, United States of America (USA) 0.01
NIH NIEHS Genome Integrity and Structural Biology Laboratory, United States of America (USA) 0.01
Department of Biomolecular Engineering (BME), UCSC, United States of America (USA) 0.01
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.01
Brandeis University, United States of America (USA) 0.01
QIMR Berghofer Department of Genetics and Computational Biology, Australia 0.01
RIKEN Center for Integrative Medical Sciences (IMS), Japan 0.01
New York Genome Center (NYGC), United States of America (USA) 0.01
Institute of Medical Science (IMSUT), UTokyo, Japan 0.01
Cancer Research Institute, BIDMC, United States of America (USA) 0.01
NIH NIEHS Integrative Bioinformatics Support Group, United States of America (USA) 0.01
Department of Biochemistry, Microbiology and Immunology, uOttawa, Canada 0.01
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.01
Department of Haematology, University of Cambridge, United Kingdom (UK) 0.01
IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy 0.01
Department of Oncology and Hemato-Oncology (DIPO), UNIMI, Italy 0.01
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.01
German Consortium of Translational Cancer Research (DKTK), Germany 0.01
Oxford Big Data Institute (BDI), United Kingdom (UK) 0.01
Yale Department of Computer Science, United States of America (USA) 0
Tri-Institutional MD-PhD Program, United States of America (USA) 0
Korea Advanced Institute of Science and Technology (KAIST), South Korea 0
Ben May Department for Cancer Research (BMDCR), UChicago, United States of America (USA) 0
Department of Human Genetics, UChicago, United States of America (USA) 0
Faculty of Biosciences, Uni Heidelberg, Germany 0
Institute for Research in Biomedicine (IRB Barcelona), BIST, Spain 0
KAIST Graduate School of Medical Science and Engineering, South Korea 0
Faculty of Science and Technology, UVic-UCC, Spain 0
USC Department of Biochemistry and Molecular Biology, Spain 0
Department of Pathology, University of Cambridge, United Kingdom (UK) 0
Center for Medical Innovation (CMI), SNU, South Korea 0
UAB School of Medicine (SOM), United States of America (USA) 0
European Bioinformatics Institute (EMBL-EBI), United Kingdom (UK) 0
Junior Research Group Pediatric Glioma Research, DKFZ, Germany 0
Hopp Children's Cancer Center Heidelberg (KiTZ), Germany 0
Weill Cornell Medicine (WCM), Cornell University, United States of America (USA) 0
Center for Cancer Research, MGH, United States of America (USA) 0
Department of Pathology, JHU, United States of America (USA) 0
Skolkovo Institute of Science and Technology (Skoltech), Russia 0
Queensland Centre for Medical Genomics (QCMG), UQ, Australia 0
Galicia Sur Health Research Institute (IISGS), Spain 0
Pompeu Fabra University (UPF), Spain 0
Institute of Medical Genetics and Applied Genomics, Uni Tübingen, Germany 0
Centre for Genomic Regulation (CRG), BIST, Spain 0
Sanger Institute Experimental Cancer Genetics, United Kingdom (UK) 0
Centre for Molecular Informatics, University of Cambridge, United Kingdom (UK) 0
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK) 0
The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine (ICB), Cornell University, United States of America (USA) 0
Caryl and Israel Englander Institute for Precision Medicine (IPM), Cornell University, United States of America (USA) 0
Department of Physiology and Biophysics, Cornell University, United States of America (USA) 0
A.A. Kharkevich Institute for Information Transmission Problems (IITP), RAS, Russia 0
Heidelberg Center for Personalized Oncology (DKFZ-HIPO), Germany 0
Federal Research Center of Pediatric Hematology, Oncology and Immunology - Dmitry Rogachev, Russia 0
Department of Pharmacology and Toxicology, U of T, Canada 0
University of California, Los Angeles (UCLA), United States of America (USA) 0
Charité Department of Urology, Germany 0
Computational Biology Program, OICR, Canada 0
Department of Medical Biophysics, U of T, Canada 0
Department of Computer Science (CS), Princeton University, United States of America (USA) 0
School of Medicine, University of St Andrews, United Kingdom (UK) 0
School of Mathematics and Statistics, University of St Andrews, United Kingdom (UK) 0
Department of Medical Oncology, UniBE, Switzerland 0
Department of Pathology, UniMelb, Australia 0

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER